From Medscape Oncology

Coverage from the

International Waldenstrom's Macroglobulinemia Foundation (IWMF) 2018 Forum

May 18 - 20, 2018; Rosemont, Illinois

May 18 - 20, 2018 Rosemont, Illinois
  • IWMF 2018 New Drugs Poised to Expand Treatment Horizons in WM New drug combinations and pathways continue to be mined in an effort to expand treatment horizons for control of a rare lymphoma and extend quality of life for patients over many years to come.
  • IWMF 2018 Patience Needed: WM Is Incurable, but Survival Is Long Management of the rare lymphoma Waldenstrom's macroglobulinemia (WM) takes patience and practice to maximize longevity and keep symptoms at bay over the long haul.

Conference News

Popular Waldenstrom's Macroglobulinemia News

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.